---
title: "ACH: Q3 underperformance prompts an operational turnaround and a sharp reduction to FY 2026 EBITDA expectations"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304544872.md"
description: "Q3 results missed expectations, with adjusted EBITDA of $47.8 million and revenue down 1% excluding specified impacts. A turnaround targets referral growth, patient retention, collections, and cost efficiency; FY 2026 adjusted EBITDA is now expected up to 30% below prior guidance midpoint.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-11-05T23:41:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304544872.md)
  - [en](https://longbridge.com/en/news/304544872.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304544872.md)
generator: "portal-rs"
---

# ACH: Q3 underperformance prompts an operational turnaround and a sharp reduction to FY 2026 EBITDA expectations

Q3 results missed expectations, with adjusted EBITDA of $47.8 million and revenue down 1% excluding specified impacts. A turnaround targets referral growth, patient retention, collections, and cost efficiency; FY 2026 adjusted EBITDA is now expected up to 30% below prior guidance midpoint.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ACHV.US](https://longbridge.com/en/quote/ACHV.US.md)
- [QUIT.US](https://longbridge.com/en/quote/QUIT.US.md)

## Related News & Research

- [Achieve Life Sciences Q3 net loss and loss per share beat estimates](https://longbridge.com/en/news/305016626.md)
- [Achieve Life Sciences highlights cytisinicline path to FDA approval, commercial launch in corporate presentation](https://longbridge.com/en/news/297831685.md)
- [Intel (INTC) Pushes Deeper Into AI With New Industrial And Enterprise Deals](https://longbridge.com/en/news/305011952.md)
- [Nebius Group Draws Fresh Scrutiny Over AI Data Center Permits](https://longbridge.com/en/news/304920937.md)
- [QBTS: Revenue rose 21%; nine-month bookings surged 611% as adjusted losses widened](https://longbridge.com/en/news/305007924.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**